Benzinga | Nov 1, 2021 11:02AM EDT

Preview: Sage Therapeutics's Earnings

Sage Therapeutics (NASDAQ:SAGE) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement.

Analysts estimate that Sage Therapeutics will likely report an Earnings Per Share (EPS) of $-1.85

Sage Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat on EPS by 8.28%, which was followed by a 0.26% drop in the share price the next day.

Here's a look at Sage Therapeutics's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020EPS Estimate -1.69 -1.91 -0.35 -2.39EPS Actual -1.83 -1.64 18.19 -2.03Price Change % -0.26% -0.48% -1.87% -0.06%

Stock Performance

Shares of Sage Therapeutics were trading at $40.36 as of October 29. Over the last 52-week period, shares are down 43.35%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.